Eric L. STANGELAND

Person

PACIFICA, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
- Patent number 11,723,900
- Issue date Aug 15, 2023
- Theravance Biopharma R&D IP, LLC
- Lori Jean Patterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
- Patent number 10,946,007
- Issue date Mar 16, 2021
- Theravance Biopharma R&D IP, LLC
- Lori Jean Patterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and β2 adre...
- Patent number 10,836,744
- Issue date Nov 17, 2020
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
- Patent number 10,722,504
- Issue date Jul 28, 2020
- Theravance Biopharma R&D IP, LLC
- Lori Jean Patterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and Beta2 a...
- Patent number 10,590,107
- Issue date Mar 17, 2020
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
- Patent number 10,441,579
- Issue date Oct 15, 2019
- Theravance Biopharma R&D IP, LLC
- Lori Jean Patterson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and β2 adre...
- Patent number 10,358,433
- Issue date Jul 23, 2019
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
- Patent number 10,206,913
- Issue date Feb 19, 2019
- Theravance Biopharma R&D IP, LLC
- Lori Jean Patterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diamide compounds having muscarinic receptor antagonis and beta2 ad...
- Patent number 10,138,220
- Issue date Nov 27, 2018
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
- Patent number 10,034,870
- Issue date Jul 31, 2018
- Theravance Biopharma R&D IP, LLC
- Lori Jean Patterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and Beta2 a...
- Patent number 9,975,875
- Issue date May 22, 2018
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and β2 adre...
- Patent number 9,771,350
- Issue date Sep 26, 2017
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and β2 adr...
- Patent number 9,682,957
- Issue date Jun 20, 2017
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
- Patent number 9,675,599
- Issue date Jun 13, 2017
- Theravance Biopharma R&D IP, LLC
- Lori Jean Patterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and β2 adre...
- Patent number 9,572,802
- Issue date Feb 21, 2017
- Theravance Respiratory Company LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of hepatitic C virus
- Patent number 9,260,414
- Issue date Feb 16, 2016
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3-phenoxymethylpyrrolidine compounds
- Patent number 9,227,933
- Issue date Jan 5, 2016
- Theravance Biopharma R&D IP, LLC
- Eric Stangeland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine...
- Patent number 9,187,423
- Issue date Nov 17, 2015
- Theravance Biopharma R&D IP, LLC
- Eric L. Stangeland
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-[2-(2-fluorophenoxy methyl)phenyl]piperidine compounds
- Patent number 9,162,982
- Issue date Oct 20, 2015
- Theravance Biopharma R&D IP, LLC
- Lori Jean Patterson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1-(2-phenoxymethylphenyl)piperazine compounds
- Patent number 9,012,460
- Issue date Apr 21, 2015
- Theravance Biopharma R&D IP, LLC
- Eric L. Stangeland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Serotonin reuptake inhibitors
- Patent number 9,000,191
- Issue date Apr 7, 2015
- Theravance Biopharma R&D IP, LLC
- Eric L. Stangeland
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and β2 adre...
- Patent number 9,000,173
- Issue date Apr 7, 2015
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3-(phenoxyphenylmethyl)pyrrolidine compounds
- Patent number 8,933,249
- Issue date Jan 13, 2015
- Theravance Biopharma R&D IP, LLC
- Eric L. Stangeland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of hepatitis C virus
- Patent number 8,921,372
- Issue date Dec 30, 2014
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-phenoxymethylpyrrolidine compounds
- Patent number 8,853,255
- Issue date Oct 7, 2014
- Theravance Biopharma R&D IP, LLC
- Eric L. Stangeland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and β2 adre...
- Patent number 8,816,088
- Issue date Aug 26, 2014
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine...
- Patent number 8,802,857
- Issue date Aug 12, 2014
- Theravance Biopharma R&D IP, LLC
- Eric L. Stangeland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1-(2-phenoxymethylphenyl)piperazine compounds
- Patent number 8,778,949
- Issue date Jul 15, 2014
- Theravance Biopharma R&D IP, LLC
- Eric L. Stangeland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Serotonin reuptake inhibitors
- Patent number 8,729,119
- Issue date May 20, 2014
- Theravance, Inc.
- Eric L. Stangeland
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Serotonin reuptake inhibitors
- Patent number 8,637,568
- Issue date Jan 28, 2014
- Theravance, Inc.
- Eric L. Stangeland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS
- Publication number 20220087995
- Publication date Mar 24, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- Lori Jean Patterson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20210024493
- Publication date Jan 28, 2021
- Theravance Respiratory Company, LLC
- Adam D. HUGHES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS
- Publication number 20200316048
- Publication date Oct 8, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Lori Jean Patterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20200165223
- Publication date May 28, 2020
- Theravance Respiratory Company, LLC
- Adam D. HUGHES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS
- Publication number 20200000792
- Publication date Jan 2, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Lori Jean Patterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20190300504
- Publication date Oct 3, 2019
- Theravance Respiratory Company, LLC
- Adam D. HUGHES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS
- Publication number 20190134019
- Publication date May 9, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Lori Jean Patterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20190047984
- Publication date Feb 14, 2019
- Theravance Respiratory Company, LLC
- Adam D. HUGHES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS
- Publication number 20180289687
- Publication date Oct 11, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- Lori Jean Patterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS
- Publication number 20180050024
- Publication date Feb 22, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- Lori Jean Patterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20170362200
- Publication date Dec 21, 2017
- Theravance Respiratory Compa, LLC
- Adam D. HUGHES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20170226082
- Publication date Aug 10, 2017
- Theravance Respiratory Company, LLC
- Adam D. HUGHES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20170096412
- Publication date Apr 6, 2017
- Theravance Respiratory Company, LLC
- Adam D. HUGHES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20160361304
- Publication date Dec 15, 2016
- THERAVANCE RESPIRATORY COMPANY, LLC
- Adam D. HUGHES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS
- Publication number 20160184288
- Publication date Jun 30, 2016
- THERAVANCE BIOPHARMA R&D IP, LLC
- Lori Jean Patterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-PHENOXYMETHYLPYRROLIDINE COMPOUNDS
- Publication number 20150126577
- Publication date May 7, 2015
- THERAVANCE BIOPHARMA R&D IP, LLC
- Eric Stangeland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL INHIBITORS OF HEPATITIC C VIRUS
- Publication number 20150071878
- Publication date Mar 12, 2015
- THERAVANCE BIOPHARMA R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 A...
- Publication number 20140323733
- Publication date Oct 30, 2014
- THERAVANCE RESPIRATORY COMPANY, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR PREPARING 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE...
- Publication number 20140323735
- Publication date Oct 30, 2014
- THERAVANCE BIOPHARMA R&D IP, LLC
- Eric L. Stangeland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
1-(2-PHENOXYMETHYLPHENYL)PIPERAZINE COMPOUNDS
- Publication number 20140288089
- Publication date Sep 25, 2014
- THERAVANCE BIOPHARMA R&D IP, LLC
- Eric L. Stangeland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SEROTONIN REUPTAKE INHIBITORS
- Publication number 20140243536
- Publication date Aug 28, 2014
- Theravance, Inc.
- Eric L. Stangeland
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-[2-(2-FLUOROPHENOXY METHYL)PHENYL]PIPERIDINE COMPOUNDS
- Publication number 20140057944
- Publication date Feb 27, 2014
- Theravance, Inc.
- Lori Jean Patterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2...
- Publication number 20130331364
- Publication date Dec 12, 2013
- Theravance, Inc.
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
1-(2-PHENOXYMETHYLHETEROARYL) PIPERIDINE AND PIPERAZINE COMPOUNDS
- Publication number 20130324550
- Publication date Dec 5, 2013
- Theravance, Inc.
- Eric L. Stangeland
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SEROTONIN REUPTAKE INHIBITORS
- Publication number 20130296322
- Publication date Nov 7, 2013
- Theravance, Inc.
- Eric L. Stangeland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SEROTONIN REUPTAKE INHIBITORS
- Publication number 20130253013
- Publication date Sep 26, 2013
- Theravance, Inc.
- Eric L. Stangeland
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-PHENOXYMETHYLPYRROLIDINE COMPOUNDS
- Publication number 20130237581
- Publication date Sep 12, 2013
- Theravance, Inc.
- Eric L. Stangeland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-(PHENOXYPHENYLMETHYL)PYRROLIDINE COMPOUNDS
- Publication number 20130178509
- Publication date Jul 11, 2013
- Theravance, Inc.
- Eric Stangeland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIPHENYL DERIVATIVES
- Publication number 20130150404
- Publication date Jun 13, 2013
- Theravance, Inc.
- Mathai Mammen
- G01 - MEASURING TESTING
Information Patent Application
DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 A...
- Publication number 20130137665
- Publication date May 30, 2013
- Theravance, Inc.
- Adam Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Eric L. STANGELAND

Person

Patents Grantslast 30 patents

4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

Diamide compounds having muscarinic receptor antagonist and β2 adre...

4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

Diamide compounds having muscarinic receptor antagonist and Beta2 a...

4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

Diamide compounds having muscarinic receptor antagonist and β2 adre...

4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

Diamide compounds having muscarinic receptor antagonis and beta2 ad...

4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

Diamide compounds having muscarinic receptor antagonist and Beta2 a...

Diamide compounds having muscarinic receptor antagonist and β2 adre...

Diamide compounds having muscarinic receptor antagonist and β2 adr...

4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

Diamide compounds having muscarinic receptor antagonist and β2 adre...

Inhibitors of hepatitic C virus

3-phenoxymethylpyrrolidine compounds

Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine...

4-[2-(2-fluorophenoxy methyl)phenyl]piperidine compounds

1-(2-phenoxymethylphenyl)piperazine compounds

Serotonin reuptake inhibitors

Diamide compounds having muscarinic receptor antagonist and β2 adre...

3-(phenoxyphenylmethyl)pyrrolidine compounds

Inhibitors of hepatitis C virus

3-phenoxymethylpyrrolidine compounds

Diamide compounds having muscarinic receptor antagonist and β2 adre...

Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine...

1-(2-phenoxymethylphenyl)piperazine compounds

Serotonin reuptake inhibitors

Serotonin reuptake inhibitors

Patents Applicationslast 30 patents

4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS

4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS

3-PHENOXYMETHYLPYRROLIDINE COMPOUNDS

NOVEL INHIBITORS OF HEPATITIC C VIRUS

DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 A...

PROCESS FOR PREPARING 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE...

1-(2-PHENOXYMETHYLPHENYL)PIPERAZINE COMPOUNDS

SEROTONIN REUPTAKE INHIBITORS

4-[2-(2-FLUOROPHENOXY METHYL)PHENYL]PIPERIDINE COMPOUNDS

DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2...

1-(2-PHENOXYMETHYLHETEROARYL) PIPERIDINE AND PIPERAZINE COMPOUNDS

SEROTONIN REUPTAKE INHIBITORS

SEROTONIN REUPTAKE INHIBITORS

3-PHENOXYMETHYLPYRROLIDINE COMPOUNDS

3-(PHENOXYPHENYLMETHYL)PYRROLIDINE COMPOUNDS

BIPHENYL DERIVATIVES

DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 A...